IRS requests public comments on tax information security guidelines for federal, state, and local agencies under the Paperwork Reduction Act of 1995.
HHS Office of the Secretary seeks 60-day public comment on a proposed information collection request under the Paperwork Reduction Act of 1995.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
The U.S. Department of Commerce is automatically initiating five-year reviews of existing antidumping and countervailing duty orders and suspended investigations under the Tariff Act of 1930.
The Office of Refugee Resettlement seeks OMB approval to extend the Annual Survey of Refugees data collection through 2027, surveying refugee households that entered the U.S. within the previous five fiscal years.
Final rule streamlines Runaway and Homeless Youth Program regulations by removing duplicative requirements to reduce administrative burden on eligible service providers and grantees.
HHS terminates the COVID-19 emergency use authorization for drugs and biological products, effective June 29, 2027.
HHS terminates three emergency use authorizations for COVID-19 medical devices, including diagnostics and respiratory protective equipment, effective December 26, 2026.
The SBA and HUD are establishing a computer matching program under the Privacy Act of 1974 to share delinquent federal debt data through the Credit Alert Verification Reporting System (CAIVRS) for federal loan eligibility screening.
IRS proposes to raise dollar thresholds for information reporting requirements on business payments and modify wagering loss limitations, with a public hearing scheduled following the April 17, 2026 Federal Register notice.
National Cancer Institute offers licensing opportunities for a conserved viral peptide therapeutic candidate for hepatocellular carcinoma prevention and treatment through research co-development partnerships.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
